HLA-G
From Wikipedia, the free encyclopedia
HLA-G histocompatibility antigen, class I, G
|
||||||||||||||
PDB rendering based on 1ydp. | ||||||||||||||
Available structures: 1ydp, 2d31, 2dyp | ||||||||||||||
Identifiers | ||||||||||||||
Symbol(s) | HLA-G; MHC-G | |||||||||||||
External IDs | OMIM: 142871 MGI: 95936 HomoloGene: 83263 | |||||||||||||
|
||||||||||||||
RNA expression pattern | ||||||||||||||
Orthologs | ||||||||||||||
Human | Mouse | |||||||||||||
Entrez | 3135 | 15018 | ||||||||||||
Ensembl | ENSG00000206443 | n/a | ||||||||||||
Uniprot | P17693 | n/a | ||||||||||||
Refseq | NM_002127 (mRNA) NP_002118 (protein) |
XM_001004111 (mRNA) XP_001004111 (protein) |
||||||||||||
Location | Chr c6_COX: 29.94 - 29.94 Mb | n/a | ||||||||||||
Pubmed search | [1] | [2] |
HLA-G histocompatibility antigen, class I, G, also known as HLA-G, or Human Leukocyte Antigen G, is a human gene.
HLA-G belongs to the HLA nonclassical class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. HLA-G is expressed on fetal derived placental cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domain, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exon 6 encodes the cytoplasmic tail.[1]
[edit] References
[edit] Further reading
- Arnaiz-Villena A, Martinez-Laso J, Alvarez M, et al. (1997). "Primate Mhc-E and -G alleles.". Immunogenetics 46 (4): 251–66. PMID 9218527.
- Le Bouteiller P (2000). "HLA-G in the human placenta: expression and potential functions.". Biochem. Soc. Trans. 28 (2): 208–12. PMID 10816129.
- Geyer M, Fackler OT, Peterlin BM (2001). "Structure--function relationships in HIV-1 Nef.". EMBO Rep. 2 (7): 580–5. doi: . PMID 11463741.
- Langat DK, Hunt JS (2003). "Do nonhuman primates comprise appropriate experimental models for studying the function of human leukocyte antigen-G?". Biol. Reprod. 67 (5): 1367–74. PMID 12390864.
- Moreau P, Dausset J, Carosella ED, Rouas-Freiss N (2003). "Viewpoint on the functionality of the human leukocyte antigen-G null allele at the fetal-maternal interface.". Biol. Reprod. 67 (5): 1375–8. PMID 12390865.
- Moreau P, Rousseau P, Rouas-Freiss N, et al. (2002). "HLA-G protein processing and transport to the cell surface.". Cell. Mol. Life Sci. 59 (9): 1460–6. PMID 12440768.
- Greenway AL, Holloway G, McPhee DA, et al. (2004). "HIV-1 Nef control of cell signalling molecules: multiple strategies to promote virus replication.". J. Biosci. 28 (3): 323–35. PMID 12734410.
- Bénichou S, Benmerah A (2003). "[The HIV nef and the Kaposi-sarcoma-associated virus K3/K5 proteins: "parasites"of the endocytosis pathway]". Med Sci (Paris) 19 (1): 100–6. PMID 12836198.
- Le Bouteiller P, Legrand-Abravanel F, Solier C (2004). "Soluble HLA-G1 at the materno-foetal interface--a review.". Placenta 24 Suppl A: S10–5. PMID 12842408.
- Sköld M, Behar SM (2003). "Role of CD1d-restricted NKT cells in microbial immunity.". Infect. Immun. 71 (10): 5447–55. PMID 14500461.
- Wiendl H, Mitsdoerffer M, Weller M (2004). "Express and protect yourself: the potential role of HLA-G on muscle cells and in inflammatory myopathies.". Hum. Immunol. 64 (11): 1050–6. PMID 14602235.
- Urosevic M, Dummer R (2004). "HLA-G in skin cancer: a wolf in sheep's clothing?". Hum. Immunol. 64 (11): 1073–80. PMID 14602238.
- Carosella ED, Moreau P, Le Maoult J, et al. (2004). "HLA-G molecules: from maternal-fetal tolerance to tissue acceptance.". Adv. Immunol. 81: 199–252. PMID 14711057.
- Leavitt SA, SchOn A, Klein JC, et al. (2004). "Interactions of HIV-1 proteins gp120 and Nef with cellular partners define a novel allosteric paradigm.". Curr. Protein Pept. Sci. 5 (1): 1–8. PMID 14965316.
- Le Maoult J, Rouas-Freiss N, Le Discorde M, et al. (2004). "[HLA-G in organ transplantation]". Pathol. Biol. 52 (2): 97–103. doi: . PMID 15001239.
- Tolstrup M, Ostergaard L, Laursen AL, et al. (2004). "HIV/SIV escape from immune surveillance: focus on Nef.". Curr. HIV Res. 2 (2): 141–51. PMID 15078178.
- Joseph AM, Kumar M, Mitra D (2005). "Nef: "necessary and enforcing factor" in HIV infection.". Curr. HIV Res. 3 (1): 87–94. PMID 15638726.
- McIntire RH, Hunt JS (2005). "Antigen presenting cells and HLA-G--a review.". Placenta 26 Suppl A: S104–9. doi: . PMID 15837058.
- Anderson JL, Hope TJ (2005). "HIV accessory proteins and surviving the host cell.". Current HIV/AIDS reports 1 (1): 47–53. PMID 16091223.